Abstract
The synthesis of sphingosine-1-phosphate (S1P) analogues has been an important subject in medicinal chemistry because of its action as selective agonists for S1P receptors. These compounds act as second messengers in the immune response controlled by the activation of T-lymphocytes. The compound VPC01091, disclosed recently by Abbott has demonstrated high selectivity for S1P1 receptors, t…